Clinical Trials · NCT04067999
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 230
- Start date
- Aug 2019
- Locations
- 16 sites, Spain
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c) (measured in percent)